Table 4 Characteristics of the general parameters for survivors and deceased in 57 outpatient clinics and 54 group home residents at baseline
From: The vital prognosis of elderly adults living in a group home in their mid-eighties
OPC (n = 57) | GH (n = 54) | |||||
|---|---|---|---|---|---|---|
Survivors (n = 43) | Deceased (n = 14) | p value | Survivors (n = 27) | Deceased (n = 27) | p value | |
Observation period, months | 43 (62–72) | 8 (27–50) | <0.001 | 72 (40–72) | 28 (13–41) | <0.001 |
Age, years | 78 (82–87) | 80 (82–86) | 0.773 | 82 (76–89) | 86 (79–92) | 0.171 |
Sex: male/female, n | 13/30 | 6/8 | 0.388 | 4/23 | 6/21 | 0.488 |
BMI, kg/m2 | 19.6 (22.9–25.2) | 17.8 (19.1–21.9) | 0.020 | 20 (18.2–23.3) | 20 (18.1–21.4) | 0.350 |
SBP, mmHg | 120 (135–150) | 110 (121–143) | 0.145 | 120 (110–134) | 116 (100–130) | 0.109 |
DBP, mmHg | 65(73–80) | 53(69–75) | 0.177 | 70(66–80) | 63(53–74) | 0.007 |
Cognitive function: categories 1/2/3 | 24/13/6 | 10/4/0 | 0.302 | 5/12/10 | 9/8/10 | 0.379 |
ADL score | 55 (90–100) | 64 (85–100) | 0.856 | 60 (15–90) | 65 (0–85) | 0.917 |
Medication | ||||||
EPA drug administration | 16 (37 %) | 5 (36 %) | 0.920 | 27 (100 %) | 6 (22 %) | <0.001 |
Other medications | ||||||
Antithrombotic agent | 16 (37 %) | 9 (64 %) | 0.076 | 10 (37 %) | 5 (19 %) | 0.129 |
Antihypertensive agent | 34 (79 %) | 10 (71 %) | 0.554 | 16 (59 %) | 14 (52 %) | 0.584 |
Diuretic or inotropic drug | 6 (14 %) | 5 (36 %) | 0.073 | 9 (33 %) | 11 (41 %) | 0.573 |
Antianginal drugs | 8 (19 %) | 4(29 %) | 0.427 | 2 (7 %) | 2 (7 %) | 1.000 |
Anti-dementia agent | 5 (12 %) | 1(7 %) | 0.635 | 9 (33 %) | 4 (15 %) | 0.111 |
Hypoglycemic agent | 6 (14 %) | 1(7 %) | 0.500 | 1 (4 %) | 3 (11 %) | 0.299 |
Dyslipidemia medication | 13 (30 %) | 4 (29 %) | 0.906 | 10 (37 %) | 6 (22 %) | 0.233 |
Antiarrhythmic agent | 4 (9 %) | 3 (21 %) | 0.230 | 1 (4 %) | 0 (0 %) | 0.313 |